The Food and Drug Administration (FDA) warned consumers not to use American Bullie A.B. Bull Pizzle Puppy Chews and Dog Chews manufactured and distributed by T.W. Enterprises, Ferndale, WA, because they have the potential to be contaminated with Salmonella, which can cause serious infections in dogs and cats, and, if there is cross contamination, in people, especially children, the aged, and people with compromised immune systems.
Eating apples while pregnant may give new meaning to an apple a day keeping the doctor away. Compelling new research has concluded that mothers who eat apples during pregnancy may protect their children from developing asthma later in life.
A study of herbal kelp supplements led by UC Davis public health expert Marc Schenker concludes that its medicinal use may cause inadvertent arsenic poisoning and health dangers for consumers, especially when overused. Schenker and two researchers evaluated nine over-the-counter herbal kelp products and found higher than acceptable arsenic levels in eight of them.
Ventracor has received approval from the US Food & Drug Administration to begin enrolment in the US Bridge To Transplant (BTT) Pivotal Trial of the VentrAssist Left Ventricular Assist Device (LVAD).
Milk does the body good — and may help smokers break the habit, say researchers at Duke University Medical Center.
The U.S. Government through the U.S. Agency for International Development (USAID) announced a three-year contract to bolster international capacity for avian and pandemic influenza response.
A Saint Louis University physician-scientist and author of a new book on how herbs, supplements, foods, vitamins and medications affect the body is researching whether an omega-3 fatty acid found in certain fish slows the progression of Alzheimer’s disease.
Eight In One, a division of United Pet Group, Inc., announced a voluntary recall across Canada of all lots of Dingo Chick?N Jerky Treats for Dogs, Cats and Ferrets.
Cephalon, Inc. (Nasdaq: CEPH) announced that it has received an approvable letter, together with draft labeling, from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) for NUVIGIL(TM) (armodafinil) Tablets [C-IV] for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS) and shift work sleep disorder (SWSD).
Cell Genesys, Inc. (Nasdaq: CEGE) announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic hormone-refractory prostate cancer (HRPC).